Nchi: Uswidi
Lugha: Kiswidi
Chanzo: Läkemedelsverket (Medical Products Agency)
pramipexoldihydrokloridmonohydrat
Ethypharm SA
N04BC05
dihydrochloride monohydrate
0,26 mg
Depottablett
pramipexoldihydrokloridmonohydrat 0,375 mg Aktiv substans
Receptbelagt
Förpacknings: Blister, 10 tabletter; Blister, 30 tabletter; Blister, 100 tabletter
Avregistrerad
2016-09-08
PACKAGE LEAFLET: INFORMATION FOR THE USER Pipexus 0.26 mg prolonged-release tablets Pipexus 0.52 mg prolonged-release tablets Pipexus 1.05 mg prolonged-release tablets Pipexus 1.57 mg prolonged-release tablets Pipexus 2.1 mg prolonged-release tablets Pipexus 2.62 mg prolonged-release tablets Pipexus 3.15 mg prolonged-release tablets pramipexole READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor, pharmacist or nurse . - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4 WHAT IS IN THIS LEAFLET 1. What Pipexus is and what it is used for 2. What you need to know before you take Pipexus 3. How to take Pipexus 4. Possible side effects 5. How to store Pipexus 6. Contents of the pack and other information 1. WHAT PIPEXUS IS AND WHAT IT IS USED FOR Pipexus contains the active substance pramipexole and belongs to a group of medicines known as dopamine agonists, which stimulate dopamine receptors in the brain. Stimulation of the dopamine receptors triggers nerve impulses in the brain that help to control body movements. Pipexus is used to treat the symptoms of primary Parkinson’s disease in adults. It can be used alone or in combination with levodopa (another medicine for Parkinson’s disease). 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE PIPEXUS DO NOT TAKE PIPEXUS - if you are allergic to pramipexole or to any of the other ingredients of this medicine (listed in section 6). WARNINGS AND PRECAUTIONS Talk to your doctor before taking Pipexus. Tell your doctor if you have (had) or develop any medical conditions or symptoms, especially any of the following: - Kidney disease. - Hallucinations (seeing, he Soma hati kamili
1 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Pipexus 0.26 mg prolonged-release tablets Pipexus 0.52 mg prolonged-release tablets Pipexus 1.05 mg prolonged-release tablets Pipexus 1.57 mg prolonged-release tablets Pipexus 2.1 mg prolonged-release tablets Pipexus 2.62 mg prolonged-release tablets Pipexus 3.15 mg prolonged-release tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Pipexus 0.26 mg prolonged-release tablets Each prolonged-release tablet contains 0.375 mg pramipexole dihydrochloride monohydrate equivalent to 0.26 mg pramipexole. Pipexus 0.52 mg prolonged-release tablets Each prolonged-release tablet contains 0.75 mg pramipexole dihydrochloride monohydrate equivalent to 0.52 mg pramipexole. Pipexus 1.05 mg prolonged-release tablets Each prolonged-release tablet contains 1.5 mg pramipexole dihydrochloride monohydrate equivalent to 1.05 mg pramipexole. Pipexus 1.57 mg prolonged-release tablets Each prolonged-release tablet contains 2.25 mg pramipexole dihydrochloride monohydrate equivalent to 1.57 mg pramipexole. Pipexus 2.10 mg prolonged-release tablets Each prolonged-release tablet contains 3 mg pramipexole dihydrochloride monohydrate equivalent to 2.1 mg pramipexole. Pipexus 2.62 mg prolonged-release tablets Each prolonged-release tablet contains 3.75 mg pramipexole dihydrochloride monohydrate equivalent to 2.62 mg pramipexole. Pipexus 3.15 mg prolonged-release tablets Each prolonged-release tablet contains 4.5 mg pramipexole dihydrochloride monohydrate equivalent to 3.15 mg pramipexole. _Please note:_ Pramipexole doses as published in the literature refer to the salt form. Therefore, doses will be expressed in terms of both pramipexole base and pramipexole salt (in brackets). 2 For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Prolonged-release tablet. Pipexus 0.26 mg prolonged-release tablets The round tablets of 9 mm diameter are white or nearly white, have a flat surface with bevelled edges and are marked with 026 on one side Pipexus 0.52 mg prolonge Soma hati kamili